Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Hunninghake

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Metabolism: Clinical and Experimental|June 1, 1981
Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemiaD B Hunninghake, J L Probstfield, L O Crow, et al.
American Journal of Hematology|April 1, 1988
Altered platelet deformability in patients with type IIa and type IV hyperlipoproteinemiaC M Smith, S M Burris, D B Hunninghake, et al.
Journal of Clinical Epidemiology|March 12, 1998
Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research GroupJ A Simon, D Grady, M C Snabes, et al.
JAMA|June 16, 1989
Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemiaL P Bell, K Hectorne, H Reynolds, et al.
The American Journal of Cardiology|September 16, 1998
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studiesJ Davignon, M Hanefeld, N Nakaya, et al.
Journal of Clinical Pharmacology|October 1, 1993
Finasteride, a steroid 5 alpha-reductase inhibitor, does not affect the oxidative metabolism of antipyrineG A Winchell, S Gregoire, A M Taylor, et al.
Controlled Clinical Trials|August 1, 1997
Recruitment for controlled clinical trials: literature summary and annotated bibliographyL C Lovato, K Hill, S Hertert, et al.
Atherosclerosis|May 1, 1984
Treatment of type III hyperlipoproteinemia with four different treatment regimensB J Hoogwerf, J P Bantle, K Kuba, et al.
Archives of Internal Medicine|October 1, 1989
Safety of long-term large doses of aspartameA S Leon, D B Hunninghake, C Bell, et al.
The American Journal of Cardiology|July 13, 1995
Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemiaF E Broyles, C E Walden, D B Hunninghake, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Metabolism: Clinical and Experimental|June 1, 1981
Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemiaD B Hunninghake, J L Probstfield, L O Crow, et al.
American Journal of Hematology|April 1, 1988
Altered platelet deformability in patients with type IIa and type IV hyperlipoproteinemiaC M Smith, S M Burris, D B Hunninghake, et al.
Journal of Clinical Epidemiology|March 12, 1998
Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research GroupJ A Simon, D Grady, M C Snabes, et al.
JAMA|June 16, 1989
Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemiaL P Bell, K Hectorne, H Reynolds, et al.
The American Journal of Cardiology|September 16, 1998
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studiesJ Davignon, M Hanefeld, N Nakaya, et al.
Journal of Clinical Pharmacology|October 1, 1993
Finasteride, a steroid 5 alpha-reductase inhibitor, does not affect the oxidative metabolism of antipyrineG A Winchell, S Gregoire, A M Taylor, et al.
Controlled Clinical Trials|August 1, 1997
Recruitment for controlled clinical trials: literature summary and annotated bibliographyL C Lovato, K Hill, S Hertert, et al.
Atherosclerosis|May 1, 1984
Treatment of type III hyperlipoproteinemia with four different treatment regimensB J Hoogwerf, J P Bantle, K Kuba, et al.
Archives of Internal Medicine|October 1, 1989
Safety of long-term large doses of aspartameA S Leon, D B Hunninghake, C Bell, et al.
The American Journal of Cardiology|July 13, 1995
Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemiaF E Broyles, C E Walden, D B Hunninghake, et al.
Pageof 12